Reproducibility of serum insulin and glucose infusion rate profiles of insulin glargine compared with NPH insulin and insulin ultralente

被引：0
|
作者：
Scholtz, HE
Becker, RHA
机构：
[1] Perexel Int, Bloemfontein, South Africa
[2] Aventis Deutschland GmbH, Clin Discovery & Human Pharmacol, Frankfurt, Germany
来源：
DIABETOLOGIA | 2004年 / 47卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
753
引用
收藏
页码：A273 / A273
页数：1
相关论文
共 50 条
  • [1] Reproducibility of serum insulin and glucose infusion rate profiles of insulin glargine compared with NPH insulin and insulin ultralente
    Scholtz, HE
    Becker, RHA
    [J]. DIABETES, 2004, 53 : A481 - A481
  • [2] THE PROFILE OF THE BIOLOGICAL EFFECT OF HUMAN ULTRALENTE INSULIN AND HUMAN NPH INSULIN COMPARED
    STARKE, AAR
    HEINEMANN, L
    HOHMANN, A
    BERGER, M
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1989, 114 (16) : 618 - 622
  • [3] Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro
    Lepore, M
    Pampanelli, S
    Fanelli, C
    Porcellati, F
    Bartocci, L
    Di Vincenzo, A
    Cordoni, C
    Costa, E
    Brunetti, P
    Bolli, GB
    [J]. DIABETES, 2000, 49 (12) : 2142 - 2148
  • [4] INSULIN GLARGINE COMPARED TO INSULIN NPH FOR THE MANAGEMENT OF HYPERGLYCEMIA IN THE CRITICALLY ILL
    Trang, Joseph
    Fox, Marlena
    Danesh, Valerie
    Jones, Timothy
    [J]. CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [5] Plasma glucose profiles in patients with type 1 diabetes treated with insulin glargine or NPH insulin
    Garg, SK
    Chase, HP
    Marshall, G
    [J]. DIABETES, 2001, 50 : A435 - A436
  • [6] Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique
    Scholtz, HE
    Pretorius, SG
    Wessels, DH
    Becker, RHA
    [J]. DIABETOLOGIA, 2005, 48 (10) : 1988 - 1995
  • [7] Risk of breast cancer in women initiating insulin glargine compared with insulin detemir Or NPH insulin
    Bradley, Marie C.
    Chillarige, Yoganand
    Lee, Hana
    Wu, Xiyuan
    Bright, Patricia
    Parulekar, Shruti
    Wernecke, Michael
    Soukup, Mat
    Kelman, Jeffrey A.
    Graham, David J.
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 146 - 146
  • [8] Pharmacokinetic and glucodynamic variability: assessment of insulin glargine, NPH insulin and insulin ultralente in healthy volunteers using a euglycaemic clamp technique
    H. E. Scholtz
    S. G. Pretorius
    D. H. Wessels
    R. H. A. Becker
    [J]. Diabetologia, 2005, 48 : 1988 - 1995
  • [9] INSULIN GLARGINE COMPARED TO INSULIN NPH FOR THE MANAGEMENT OF HYPERGLYCEMIA IN CRITICALLY ILL PATIENTS
    Anderson, Rebecca
    Fox, Marlena
    Danesh, Valerie
    Gupta, Rakesh
    Jones, Timothy
    [J]. CRITICAL CARE MEDICINE, 2012, 40 (12) : U284 - U285
  • [10] Diabetes in Pregnancy: A Meta-Analysis of the Safety of Insulin Glargine Compared with NPH Insulin
    Lepercq, Jacques
    Lin, Jay
    Hall, Gillian
    Dain, Marie-Paule
    Riddle, Matthew
    Home, Philip
    [J]. DIABETES, 2011, 60 : A259 - A260
12345